If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.55
Ask: 1.85
Change: 0.00 (0.00%)
Spread: 0.30 (19.355%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
LSAA Live PriceLast checked at -
Life Settlement Assets A is an Investment Trust

To generate long-term returns for investors by investing in the life settlement market.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re agreement to reduce performance fee

30 Jun 2022 07:00

RNS Number : 7164Q
Life Settlement Assets PLC
30 June 2022
 

 

LIFE SETTLEMENT ASSETS PLC (the "Company" or "LSA")

AGREEMENT OF REDUCED ACL PERFORMANCE FEE

30 June 2022

As referred to in the Company's annual results for the year ended 31 December 2021, LSA has been in discussions with Acheron Capital Limited ("ACL") regarding the re-negotiation of the performance fee payable to ACL, which is currently defined as an amount equal to 20% of the total distributions made by the Company over an agreed hurdle rate. Agreement has now been reached with ACL that once the current litigation process with one of the policy trustees has been resolved, which is expected to occur during 2022, the performance fee will be reduced from 20% as described above to 10% over the existing hurdle rate.

The resolution of the legal dispute is expected to be accompanied by a judicially approved sale of the policies in the relevant trustee portfolio. The completion of such a sale process, including LSA`s participation therein whether successful or not, would mark the end of LSA`s need to accumulate cash to purchase the relevant policies, so enabling LSA to resume further distributions to Shareholders. Assuming resolution of the dispute, following the first such distribution LSA has agreed to make a one-off payment to ACL of any accrued performance fee payable to ACL held by the Company in excess of $1m, based on the 2022 financial results and subject to the cash requirements of the business. As at 31 December 2021 the accrued performance fee stood at $2.8m. However, in acknowledgement of the significant work that ACL has had to perform with regard to engagement with the legal dispute over a long period, the Directors of LSA have agreed to make an immediate advance to ACL, subject to an agreed clawback mechanism, of $0.5m which will be credited against any amount to be paid under the above one-off payment arrangement, following the publication of the 2022 financial results.

 

For further information contact

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Robert Finlay

020 7408 4090

 

ISCA Administration Services Limited

Company Secretary

Tel: 01392 487056

 

Notes to Editors

Life Settlement Assets PLC is a closed-ended investment trust company which invests in, and manages, portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company seeks to generate long-term returns for investors by investing in the life settlement market, through each of the separate Share Classes. The Company aims to manage its investment in portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSEAFWUEESEFM
Date   Source Headline
20th Jun 20192:56 pmRNSShare Premium Account & Dividend Declaration
13th Jun 20195:31 pmRNSResult of AGM
6th Jun 20197:00 amRNSNet Asset Value(s)
4th Jun 201911:53 amRNSTender Offer
30th May 20197:00 amRNSChange of Adviser
15th May 20195:26 pmRNSReport and Accounts and AGM Notice of Meetings
14th May 20197:00 amRNSReturn of Capital
13th May 20197:00 amRNSNet Asset Value(s)
30th Apr 20195:15 pmRNSAnnual Financial Report
8th Apr 20197:00 amRNSNet Asset Value(s)
18th Mar 20199:36 amRNSNet Asset Value(s)
6th Mar 20197:00 amRNSMaturity Notice
13th Feb 20198:42 amRNSNet Asset Value(s) - Replacement
13th Feb 20197:00 amRNSNet Asset Value(s)
14th Jan 20197:00 amRNSNet Asset Value(s)
7th Jan 20193:03 pmRNSPolicy Maturities
14th Dec 20183:15 pmRNSNet Asset Value(s)
9th Nov 20187:00 amRNSNet Asset Value(s)
15th Oct 20182:17 pmRNSFinancial Results for Period ended 30 June 2018
12th Oct 20187:00 amRNSNet Asset Value(s)
1st Oct 20184:36 pmRNSStatement re (Submission of Document)
28th Sep 20184:10 pmRNSFinancial Results for Period ended 30 June 2018
25th Sep 20184:13 pmRNSChange of Registered Office
14th Sep 20187:00 amRNSNet Asset Value(s)
13th Aug 20187:00 amRNSNet Asset Value(s)
12th Jul 20187:00 amRNSNet Asset Value(s)
9th Jul 20187:00 amRNSStatement re Share Dealing
29th Jun 20182:25 pmRNSStatement re Share Dealings
19th Jun 201812:00 pmRNSStatement re Company Presentation
15th Jun 20187:00 amRNSNet Asset Value(s)
31st May 20189:19 amRNSNet Asset Value(s)
21st May 20189:45 amRNSHolding(s) in Company
10th May 20187:00 amRNSStatement re Policy Maturities
20th Apr 201810:42 amRNSHolding(s) in Company
3rd Apr 20181:56 pmRNSTotal Voting Rights
3rd Apr 201811:42 amRNSHolding(s) in Company
26th Mar 20188:05 amRNSAdmission to the Specialist Fund Segment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.